Interestingly, Lee et al. observed a significantly higher CD28 mRNA level compared to CTLA-4 in patients with lymph node metastasis versus metastasis-free group in colon cancer, which, along with immunohistochemical analysis, might be a promising diagnostic tool for determining cancer progression [57]. Here, CD28 is linked to metastatic malignant neoplasm in the lymph nodes.